CirChem Financial Statements From 2010 to 2024

CIRCHE Stock  SEK 2.91  0.05  1.75%   
CirChem AB financial statements provide useful quarterly and yearly information to potential CirChem AB investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on CirChem AB financial statements helps investors assess CirChem AB's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting CirChem AB's valuation are summarized below:
CirChem AB does not presently have any fundamental signals for analysis.
Check CirChem AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CirChem AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . CirChem financial statements analysis is a perfect complement when working with CirChem AB Valuation or Volatility modules.
  
This module can also supplement various CirChem AB Technical models . Check out the analysis of CirChem AB Correlation against competitors.

CirChem AB Company Current Valuation Analysis

CirChem AB's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current CirChem AB Current Valuation

    
  56.2 M  
Most of CirChem AB's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CirChem AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, CirChem AB has a Current Valuation of 56.2 M. This is 99.23% lower than that of the Industrials sector and 85.29% lower than that of the Pollution & Treatment Controls industry. The current valuation for all Sweden stocks is 99.66% higher than that of the company.

CirChem AB Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CirChem AB's current stock value. Our valuation model uses many indicators to compare CirChem AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CirChem AB competition to find correlations between indicators driving CirChem AB's intrinsic value. More Info.
CirChem AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value CirChem AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CirChem AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About CirChem AB Financial Statements

CirChem AB stakeholders use historical fundamental indicators, such as CirChem AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although CirChem AB investors may analyze each financial statement separately, they are all interrelated. For example, changes in CirChem AB's assets and liabilities are reflected in the revenues and expenses on CirChem AB's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CirChem AB. Please read more on our technical analysis and fundamental analysis pages.
CirChem AB engages in recycling of used solvents in Sweden. The company was founded in 2013 and is based in Vargon, Sweden. CirChem AB is traded on Stockholm Stock Exchange in Sweden.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in CirChem Stock

CirChem AB financial ratios help investors to determine whether CirChem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CirChem with respect to the benefits of owning CirChem AB security.